Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jenster

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Nature|March 15, 1990
Acute leukaemia in bcr/abl transgenic miceN Heisterkamp, G Jenster, J ten Hoeve, et al.
Advances in Experimental Medicine and Biology|November 5, 2015
Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical AspectsJ W Salman, I G Schoots, S V Carlsson, et al.
Molecular and Cellular Endocrinology|November 6, 2001
Androgen regulation of the cell-cell adhesion molecule-1 (Ceacam1) geneD Phan, X Sui, D T Chen, et al.
Molecular and Cellular Endocrinology|October 18, 2001
Repression of androgen-regulated gene expression by dominant negative androgen receptorsK S Bramlett, N F Dits, X Sui, et al.
Progress in Histochemistry and Cytochemistry|January 1, 1992
Multi-assay performance of a monoclonal antibody directed against the androgen receptorT H van der Kwast, N D Zegers, G Jenster, et al.
Steroids|April 1, 1996
Molecular basis of androgen insensitivityA Brinkmann, G Jenster, C Ris-Stalpers, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Steroid receptor induction of gene transcription: a two-step modelG Jenster, T E Spencer, M M Burcin, et al.
The Journal of Biological Chemistry|March 27, 1999
Specific androgen receptor activation by an artificial coactivatorX Sui, K S Bramlett, M C Jorge, et al.
British Journal of Cancer|February 13, 2014
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cellsD J P Henderson, A Byrne, K Dulla, et al.
Biochemistry|November 29, 1994
Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sitesG Jenster, P E de Ruiter, H A van der Korput, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Nature|March 15, 1990
Acute leukaemia in bcr/abl transgenic miceN Heisterkamp, G Jenster, J ten Hoeve, et al.
Advances in Experimental Medicine and Biology|November 5, 2015
Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical AspectsJ W Salman, I G Schoots, S V Carlsson, et al.
Molecular and Cellular Endocrinology|November 6, 2001
Androgen regulation of the cell-cell adhesion molecule-1 (Ceacam1) geneD Phan, X Sui, D T Chen, et al.
Molecular and Cellular Endocrinology|October 18, 2001
Repression of androgen-regulated gene expression by dominant negative androgen receptorsK S Bramlett, N F Dits, X Sui, et al.
Progress in Histochemistry and Cytochemistry|January 1, 1992
Multi-assay performance of a monoclonal antibody directed against the androgen receptorT H van der Kwast, N D Zegers, G Jenster, et al.
Steroids|April 1, 1996
Molecular basis of androgen insensitivityA Brinkmann, G Jenster, C Ris-Stalpers, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 1997
Steroid receptor induction of gene transcription: a two-step modelG Jenster, T E Spencer, M M Burcin, et al.
The Journal of Biological Chemistry|March 27, 1999
Specific androgen receptor activation by an artificial coactivatorX Sui, K S Bramlett, M C Jorge, et al.
British Journal of Cancer|February 13, 2014
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cellsD J P Henderson, A Byrne, K Dulla, et al.
Biochemistry|November 29, 1994
Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sitesG Jenster, P E de Ruiter, H A van der Korput, et al.
Pageof 4